Clinical Trial Update: Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sub-dissociative ketamine and fentanyl for acute moderate to severe pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Acute

Drugs mentioned

• FENTANYL (FENTANYL)
• Sub-Dissociative Ketamine (ketamine)

Snippet

Sponsor: Mercy Health Ohio | Conditions: Pain, Acute | Phase 4 | Status: TERMINATED